Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Baoquan Han, Yongyong Wang, Wei Ge, Junjie Wang, Shuai Yu, Jiamao Yan, Lei Hua, Xiaoyuan Zhang, Zihui Yan, Lu Wang, Jinxin Zhao, Cong Huang, Bo Yang, Yan Wang, Qian Ma, Yong Zhao, Hui Jiang, Yunqi Zhang, Shaolin Liang, Jianjuan Zhao, Zhongyi Sun, Wei Shen, Yaoting Gui
Format: Artículo Open Access
Veröffentlicht: Wiley 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867020956868804608
author Baoquan Han
Yongyong Wang
Wei Ge
Junjie Wang
Shuai Yu
Jiamao Yan
Lei Hua
Xiaoyuan Zhang
Zihui Yan
Lu Wang
Jinxin Zhao
Cong Huang
Bo Yang
Yan Wang
Qian Ma
Yong Zhao
Hui Jiang
Yunqi Zhang
Shaolin Liang
Jianjuan Zhao
Zhongyi Sun
Wei Shen
Yaoting Gui
author_facet Baoquan Han
Yongyong Wang
Wei Ge
Junjie Wang
Shuai Yu
Jiamao Yan
Lei Hua
Xiaoyuan Zhang
Zihui Yan
Lu Wang
Jinxin Zhao
Cong Huang
Bo Yang
Yan Wang
Qian Ma
Yong Zhao
Hui Jiang
Yunqi Zhang
Shaolin Liang
Jianjuan Zhao
Zhongyi Sun
Wei Shen
Yaoting Gui
Baoquan Han
Yongyong Wang
Wei Ge
Junjie Wang
Shuai Yu
Jiamao Yan
Lei Hua
Xiaoyuan Zhang
Zihui Yan
Lu Wang
Jinxin Zhao
Cong Huang
Bo Yang
Yan Wang
Qian Ma
Yong Zhao
Hui Jiang
Yunqi Zhang
Shaolin Liang
Jianjuan Zhao
Zhongyi Sun
Wei Shen
Yaoting Gui
collection Wiley Open Access
contents Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients Baoquan Han Yongyong Wang Wei Ge Junjie Wang Shuai Yu Jiamao Yan Lei Hua Xiaoyuan Zhang Zihui Yan Lu Wang Jinxin Zhao Cong Huang Bo Yang Yan Wang Qian Ma Yong Zhao Hui Jiang Yunqi Zhang Shaolin Liang Jianjuan Zhao Zhongyi Sun Wei Shen Yaoting Gui iMeta AbstractAsthenozoospermia (AZS) is a prevalent contributor to male infertility, characterized by a substantial decline in sperm motility. In recent years, large‐scale studies have explored the interplay between the male reproductive system's microecology and its implications for reproductive health. Nevertheless, the direct association between seminal microecology and male infertility pathogenesis remains inconclusive. This study used 16S rDNA sequencing and multi‐omics analysis to conduct a comprehensive investigation of the seminal microbial community and metabolites in AZS patients. Patients were categorized into four distinct groups: Normal, mild AZS (AZS‐I), moderate AZS (AZS‐II), and severe AZS (AZS‐III). Microbiome differential abundance analysis revealed significant differences in microbial composition and metabolite profiles within the seminal plasma of these groups. Subsequently, patients were classified into a control group (Normal and AZS‐I) and an AZS group (AZS‐II and AZS‐III). Correlation and cross‐reference analyses identified distinct microbial genera and metabolites. Notably, the AZS group exhibited a reduced abundance of bacterial genera such as Pseudomonas, Serratia, and Methylobacterium‐Methylorubrum in seminal plasma, positively correlating with core differential metabolite (hexadecanamide). Conversely, the AZS group displayed an increased abundance of bacterial genera such as Uruburuella, Vibrio, and Pseudoalteromonas, with a negative correlation with core differential metabolite (hexadecanamide). In vitro and in vivo experiments validated that hexadecanamide significantly enhanced sperm motility. Using predictive metabolite‐targeting gene analysis and single‐cell transcriptome sequencing, we profiled the gene expression of candidate target genes PAOX and CA2. Protein immunoblotting techniques validated the upregulation protein levels of PAOX and CA2 in sperm samples after hexadecanamide treatment, enhancing sperm motility. In conclusion, this study uncovered a significant correlation between six microbial genera in seminal plasma and the content of the metabolite hexadecanamide, which is related to AZS. Hexadecanamide notably enhances sperm motility, suggesting its potential integration into clinical strategies for managing AZS, providing a foundational framework for diagnostic and therapeutic advancements. 10.1002/imt2.166 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/imt2.166
format Artículo Open Access
id wiley_oa_10_1002_imt2_166
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients
Baoquan Han
Yongyong Wang
Wei Ge
Junjie Wang
Shuai Yu
Jiamao Yan
Lei Hua
Xiaoyuan Zhang
Zihui Yan
Lu Wang
Jinxin Zhao
Cong Huang
Bo Yang
Yan Wang
Qian Ma
Yong Zhao
Hui Jiang
Yunqi Zhang
Shaolin Liang
Jianjuan Zhao
Zhongyi Sun
Wei Shen
Yaoting Gui
iMeta
Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients Baoquan Han Yongyong Wang Wei Ge Junjie Wang Shuai Yu Jiamao Yan Lei Hua Xiaoyuan Zhang Zihui Yan Lu Wang Jinxin Zhao Cong Huang Bo Yang Yan Wang Qian Ma Yong Zhao Hui Jiang Yunqi Zhang Shaolin Liang Jianjuan Zhao Zhongyi Sun Wei Shen Yaoting Gui iMeta AbstractAsthenozoospermia (AZS) is a prevalent contributor to male infertility, characterized by a substantial decline in sperm motility. In recent years, large‐scale studies have explored the interplay between the male reproductive system's microecology and its implications for reproductive health. Nevertheless, the direct association between seminal microecology and male infertility pathogenesis remains inconclusive. This study used 16S rDNA sequencing and multi‐omics analysis to conduct a comprehensive investigation of the seminal microbial community and metabolites in AZS patients. Patients were categorized into four distinct groups: Normal, mild AZS (AZS‐I), moderate AZS (AZS‐II), and severe AZS (AZS‐III). Microbiome differential abundance analysis revealed significant differences in microbial composition and metabolite profiles within the seminal plasma of these groups. Subsequently, patients were classified into a control group (Normal and AZS‐I) and an AZS group (AZS‐II and AZS‐III). Correlation and cross‐reference analyses identified distinct microbial genera and metabolites. Notably, the AZS group exhibited a reduced abundance of bacterial genera such as Pseudomonas, Serratia, and Methylobacterium‐Methylorubrum in seminal plasma, positively correlating with core differential metabolite (hexadecanamide). Conversely, the AZS group displayed an increased abundance of bacterial genera such as Uruburuella, Vibrio, and Pseudoalteromonas, with a negative correlation with core differential metabolite (hexadecanamide). In vitro and in vivo experiments validated that hexadecanamide significantly enhanced sperm motility. Using predictive metabolite‐targeting gene analysis and single‐cell transcriptome sequencing, we profiled the gene expression of candidate target genes PAOX and CA2. Protein immunoblotting techniques validated the upregulation protein levels of PAOX and CA2 in sperm samples after hexadecanamide treatment, enhancing sperm motility. In conclusion, this study uncovered a significant correlation between six microbial genera in seminal plasma and the content of the metabolite hexadecanamide, which is related to AZS. Hexadecanamide notably enhances sperm motility, suggesting its potential integration into clinical strategies for managing AZS, providing a foundational framework for diagnostic and therapeutic advancements. 10.1002/imt2.166 http://creativecommons.org/licenses/by/4.0/
title Changes in seminal plasma microecological dynamics and the mechanistic impact of core metabolite hexadecanamide in asthenozoospermia patients
topic iMeta
url https://onlinelibrary.wiley.com/doi/10.1002/imt2.166